Nureca Limited (NURECA)
🎯 Key Takeaways
- Revenue declined 15.2% QoQ to ₹26 in Q3FY25.
📊 Quarterly Results (₹ Cr)
| Metric | Q4FY23 | Q1FY24 | Q2FY24 | Q3FY24 | Q4FY24 | Q1FY25 | Q2FY25 | Q3FY25 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 21 | 21 | 31 | 22 | 17 | 20 | 31 | 26 |
| Operating Profit | -1 | -0 | 5 | 2 | -6 | 3 | 1 | -3 |
| OPM % | -16.3% | -13.7% | 4.4% | -19.0% | -26.1% | -11.6% | -7.6% | -15.2% |
| Net Profit | -2 | -1 | 3 | 0 | -4 | 2 | -0 | -3 |
| EPS | ₹-1.53 | ₹-0.71 | ₹2.90 | ₹0.16 | ₹-4.15 | ₹1.66 | ₹-0.48 | ₹-2.80 |
⚖️ Peer Comparison — Healthcare Equipment & Supplies
| Company | MCap (₹ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| Poly Medicure Limited | 15,193 | 46.4 | — | — | — |
| Fischer Medical Ventures Limited | 2,261 | 59.0 | — | — | — |
| Laxmi Dental Limited | 1,105 | 57.2 | — | — | — |
| Tarsons Products Limited | 1,101 | 36.9 | — | — | — |
| Fabtech Technologies Limited | 681 | — | — | — | — |
| Nureca Limited | 260 | -47.3 | — | — | — |
🔗 Peer Stock Analyses
📋 Recent Filings
-
🔴 Insider Trading 11 August 2026Nureca Limited disclosed an insider share purchase by a designated person under SEBI PIT Regulations, Regulation 7(2), which was not automatically ref...
-
🔴 Financial Results 21 July 2026Nureca reported Q1 FY27 revenue of **₹40.3 crores**, up 14% QoQ and 18% YoY, driven by strong gross margins and operating profitability. The company p...
-
🟡 Board Meeting 21 July 2026Nureca Limited announced the unaudited standalone and consolidated financial results for Q1 FY26-27 ended June 30, 2026, showing revenue of **₹423.14 ...
-
share transfer 15 July 2026Nureca Limited received a SEBI-mandated share transfer agent certificate for the quarter ended June 30, 2026, confirming all shareholders hold shares ...
-
🔴 annual report 3 July 2026Nureca Limited's FY26 annual report shows revenue growth of 34% to ₹1,469.93 crores, EBITDA up 68.94% to [amount context mismatch] crores, and PAT sur...
-
🔴 Insider Trading 3 July 2026Mr. Aryan Goyal, a promoter group member of Nureca Limited, disposed of equity shares via an off-market transfer under a family settlement agreement d...
-
Announcement 1 July 2026Nureca Limited announced the resignation of Whole-time Director and CEO Aryan Goyal effective close of business on 1st July 2026, following a family s...
-
🟡 Board Meeting 1 July 2026No summary available
-
Announcement 20 June 2026Nureca Limited announced that its connected health platform Dr Trust 360 has crossed 2.4 million registered users and launched Dr Trust Intelligence, ...
-
Announcement 20 June 2026Nureca Limited disclosed a Family Settlement Agreement (FSA) dated June 17, 2026, involving promoter family members Saurabh Goyal, Smita Goyal, Aryan ...
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.
Sign Up Free — Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-08-15.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when NURECA files new disclosures
Track NURECA filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track NURECA — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research